Skip to content

Case-control study, 2012

Do women with PMDD have different melatonin patterns than women without PMDD?

Yes. Women with PMDD had significantly lower melatonin at night and a weaker rhythm pattern, especially during the luteal phase when symptoms occur. However, this was a very small pilot study with only 5 women per group, so findings need confirmation in larger research.

Early or limited evidence 10 women: 5 with PMDD, 5 healthy controls

What they did

Ten women (5 with PMDD, 5 controls) had two 24-hour stays in a time-isolated laboratory, one during their follicular phase and one during their luteal phase. Researchers measured mood, hormones, and melatonin throughout both stays.

What they found

Women with PMDD had significantly worse mood during the luteal phase compared to follicular phase and controls (P≤.03). They had significantly lower melatonin at night in both phases compared to controls (P<.05). Their melatonin rhythm amplitude was significantly reduced during the luteal phase. They also had reduced melatonin area under the curve during the luteal phase compared to their follicular phase.

What it means for you

Disturbed melatonin rhythm and reduced nighttime melatonin may play a role in PMDD symptoms. However, the study was very small with only 5 women per group, so findings should be confirmed in larger studies. The proposed biological mechanism involving serotonin is not yet proven.

5

women with PMDD

5

healthy controls

P<.05

significance of melatonin difference

About the study

Original title
Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder
Authors
Shechter A, Lespérance P, Ng Ying Kin NM et al.
Journal
PloS one
Year
2012
Study design
Case-control study
What was tested
Measurement of melatonin and mood patterns across menstrual cycle phases
Open access
Yes
Original abstract

Women with premenstrual dysphoric disorder (PMDD) experience mood deterioration and altered circadian rhythms during the luteal phase (LP) of their menstrual cycles. Disturbed circadian rhythms may be involved in the development of clinical mood states, though this relationship is not fully characterized in PMDD. We therefore conducted an extensive chronobiological characterization of the melatonin rhythm in a small group of PMDD women and female controls. In this pilot study, participants included five women with PMDD and five age-matched controls with no evidence of menstrual-related mood disorders. Participants underwent two 24-hour laboratory visits, during the follicular phase (FP) and LP of the menstrual cycle, consisting of intensive physiological monitoring under "unmasked", time-isolation conditions. Measures included visual analogue scale for mood, ovarian hormones, and 24-hour plasma melatonin. Mood significantly (P≤.03) worsened during LP in PMDD compared to FP and controls. Progesterone was significantly (P = .025) increased during LP compared to FP, with no between-group differences. Compared to controls, PMDD women had significantly (P<.05) decreased melatonin at circadian phases spanning the biological night during both menstrual phases and reduced amplitude of its circadian rhythm during LP. PMDD women also had reduced area under the curve of melatonin during LP compared to FP. PMDD women showed affected circadian melatonin rhythms, with reduced nocturnal secretion and amplitude during the symptomatic phase compared to controls. Despite our small sample size, these pilot findings support a role for disturbed circadian rhythms in affective disorders. Possible associations with disrupted serotonergic transmission are proposed.

Reproduced under CC-BY.

Topics